van Leeuwen, Flora H. P. http://orcid.org/0000-0002-8384-4385
Lena, Beatrice
van Bergen, Eline D. P.
van Klei, Janoah J.
Timmer, Merel A.
van Vulpen, Lize F. D.
Fischer, Kathelijn
de Jong, Pim A.
Bos, Clemens
Foppen, Wouter
Funding for this research was provided by:
NovoNordisk (Access to Insight 2018)
Article History
Received: 9 November 2023
Revised: 9 March 2024
Accepted: 10 March 2024
First Online: 21 March 2024
Declarations
:
: This study was funded by an independent clinical research grant from NovoNordisk (Access to Insight 2018) received by W. Foppen which was paid to the institution. M.A. Timmer, and L.F.D. van Vulpen have also received research grants from NovoNordisk. K. Fischer has performed consultancy for NovoNordisk and has received speaker’s fees and research support from NovoNordisk. The other authors declare no financial relationship with NovoNordisk.In addition, F.H.P. van Leeuwen, B. Lena, E.D.P. van Bergen, J.J. van Klei and C. Bos declare no conflicts of interest. M.A. Timmer has received research grants from SOBI, which were paid to the institution. L.F.D. van Vulpen has received research grants from CSL Behring and Grifols; and has performed consultancy for Sobi, CSL Behring, and Octapharma; all fees paid to the institution. K. Fischer has received speaker’s fees from Bayer, Baxter/Shire, Sobi/Biogen, CSL Behring; has performed consultancy for Bayer, Biogen, CSL Behring, Freeline, Roche and Sobi; and has received research support from Bayer, Baxter/Shire, Pfizer and Biogen; all fees were paid to the institution. P.A. de Jong declares a research collaboration with Vifor Pharma. W. Foppen has received a research grant from Pfizer, which was paid to the institution, and consultancy fees from Pfizer. The Department of Radiology & Nuclear Medicine of the UMC Utrecht has received research support from Philips Healthcare.